FDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH U.S. Food and Drug Administration Center for Devices and Radiological Health [Skip navigation]
horizonal rule

* Introduction
* 510(k) Submission Process
* 510(k) Review Fees
* Exemptions - 510(k) and GMP Requirements
* How to Find a Predicate Device
* How to Prepare a Traditional 510(k)
* How to Prepare a Special 510(k)
* How to Prepare an Abbreviated 510(k)
* Content of a 510(k)
* Format of a 510(k)
* Is a new 510(k) Required for a Modification to the Device?
* Guidance Documents
* Third Party Review Program
Skip past Top MenuDevice Advice HomeCDRH HomeComments
Search for In

Premarket Notification [510(k)] Review Fees

Overview
Fees
Exemptions and Waivers
When to Pay
How/Where to Send Payment
Qualification for Small Business Fees

Overview

On October 26, 2002 the Medical Device User Fee and Modernization Act of 2002 signed into law. This law authorizes FDA to charge a fee for medical device Premarket Notifcation 510(k) reviews. This application fee applies to most 510(k)'s including Traditional, Abbreviated, and Special 510(k)s, but not those exempted or waived as noted below. Small businesses may qualify for a reduced fee beginning in FY 2004. Payment must be received on or before the time the 510(k) submission is submitted. If the submitter has not paid all fees owed, FDA will consider the submission incomplete and will not accept it for filing.

Fees

The review fees for 510(k) submissions are below:

510(k) Review User Fees (U.S. Dollars)
  Standard Fee Small Business Fee
FY2004 (Oct. 1, 2003 - Sept. 30, 2004) $3,480 $2,784
FY2005 (Oct. 1, 2004 - Sept. 30, 2005) $3,502 $2,802

The applicable fee corresponds with the date of receipt of the submission by FDA. Please note that FDA will consider the 510(k) submission incomplete and will not accept it for filing until the fee is paid in full. That is, the date of receipt is the date that the submission has been received AND the fee is paid in full.

FDA will adjust these fees each year to account for inflation, changes in workloads, and other factors. The small business fee will be 80% of the standard fee for FY 2004 and subsequent fiscal years. FDA will announce the new fees for the next fiscal year in a Federal Register notice by August 1 of each year.

Exemptions and Waivers

The following exemptions or waivers apply:

Fee Exemptions and Waivers (No Fee for These)
Category Exemption or Waiver
Third-party 510(k) Exempt from any FDA fee; however, the third-party does charge a fee for its review.
Any application for a device intended solely for pediatric use. Exempt from user fee. Please note that changing the intended use from pediatric use to adult use requires the submission of a new 510(k). The new 510(k) is subject to the 510(k) review fee at the time of submission.
Any application from a State or Federal Government entity. Exempt from any fee unless the device is to be distributed commercially.

When to Pay

Payment must be received at or before the time the 510(k) submission is submitted. If the submitter has not paid all fees owed, FDA will consider the submission incomplete and will not accept it for filing.

How/Where to Send Payment

The review fee may be submitted by mail, courier, or wire transfer.

  • Follow the on-line instructions for completing your cover sheet. When you have provided the necessary information, click the button labeled "Transmit Cover Sheet to FDA and Continue." When you transmit your information to FDA, the system will generate a printable copy of your cover sheet. Print two copies for FDA use, and any number of copies for your own use.
  • Send a printed copy of your cover sheet with your original 510(k) submission.

  • Send a printed copy of your cover sheet with your payment. Be sure to include the Payment Identification Number (from your cover sheet) on your check, bank draft, or U.S. Postal Money Order. Send your payment to:
    1. By Mail:
      Food and Drug Administration
      P.O. Box 956733
      St. Louis, MO 63195-6733

      By Courier:
      If the check is sent by a courier, the courier may deliver the checks to:

      US Bank
      Attn: Government Lockbox 956733
      1005 Convention Plaza
      St. Louis, MO 63101

      (Note: This address is for courier delivery only. Contact the US Bank at (314) 418-4983 if you have any questions concerning courier delivery.)

Additional information, including how to submit payment by wire transfer, can be found in MDUFMA Fee Payment Instructions. Please note that the bank or financial institution usually assess a fee for sending a wire transfer. The applicant is responsible for paying all wire transfer fees. FDA will not pay any of these fees.

If needed for accounting purposes, FDA's tax identification number is 53-0196965.

Fees should arrive at the bank at least 1 day before the application arrives at FDA. FDA recommends that you send the payment to the bank 4-5 business days before the application arrives at FDA so there is no delay in starting the review of your application. FDA records as the application receipt date the latter of the following:

  1. The date the submission was received by FDA; or
  2. The date US Bank notifies FDA that payment has been received.

US Bank is required to notify FDA within 1-working day, using the Payment Identification Number.

Qualification for Small Business Fees

Beginning FY 2004 (October 1, 2003), firms with annual gross sales and revenues with $30 million or less, including gross sales and revenues of all affiliates, partners, and parent firms, may qualify for lower rates for Premarket Notification 510(k) submissions. Please note that affliliate is defined by §737(8) of the FD&C Act: An affiliate means a business entity that has a relationship with a second business entity if, directly or indirectly,

  1. one business entity controls, or has the power to control, the other business entity; or
  2. a third party controls, or has power to control, both of the business entities.

To qualify for FY 2004, the firm is required to submit the FY 2004 MDUFMA Small Business Qualification Certification (Form FDA 3602). In addition, certified copies of the firm's Federal Income Tax Return for the most recent taxable year, including certified copies of the income tax returns of all affiliates, partners, and parent firms must be provided.

The following guidance and form should be used.

FY2004 MDUFMA Small Business Qualification Worksheet and Certification http://www.fda.gov/cdrh/mdufma/guidance/1225.pdf.
FY 2004 MDUFMA Small Business Qualification Certification (Form FDA 3602) is provided as an attachment to this guidance.

FY2005 MDUFMA Small Business Qualification Worksheet and Certification http://www.fda.gov/cdrh/mdufma/guidance/2005.pdf.
FY 2004 MDUFMA Small Business Qualification Certification (Form FDA 3602) is provided as an attachment to this guidance.

The Certification should be sent to:

MDUFMA Small Business Qualification (HFZ-222)
Division of Small Manufacturers, International and Consumer Assistance
1350 Piccard Dr.
Rockville, MD 20850

FDA will review the Certification within 60 days and send its decision that the firm is, or is not, a small business eligible for reduced or waived fees. If the firm qualifies as a small business, the decision letter will include a Small Busines Decision number. The Small Business Decision number is used on the Medical Device User Fee Cover Sheet (Form FDA 3601) to demonstrate that the firm is entitled to a reduced fee. If a firm submits a reduced fee to FDA without a Small Business Decision number, the submission will not be accepted for filing.

The small business status expires at the end of each fiscal year (September 30th). A new MDUFMA Small Business Qualification Certification must be submitted each year to qualify as a small business.

Additional information on medical device user fees is available at http://www.fda.gov/cdrh/mdufma/. Please note that FDA policy on issues related to medical device user fees is still under development. FDA will post policy issues with respect to user fees on the user fee website as it becomes available.

Updated 9/2/2004

Accessibility Disclaimer

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH